Abstract
Background
The only cure for primary hyperparathyroidism (pHPT) is operative resection of the parathyroid gland(s) responsible for the disease. The 1990 National Institute of Health’s (NIH) consensus development conference on asymptomatic pHPT and its subsequent workshop in 2001 established which clinical criteria warranted parathyroidectomy (PTx) versus observation. While there is no debate that these NIH criteria capture a group of patients likely to benefit from PTx, there is concern that these guidelines miss a significant percentage of pHPT patients who actually are symptomatic. Unfortunately, these additional symptoms are often subtle, nonspecific, not traditionally measured, frequently not assessed or considered in this patient population, and are usually attributed to other diagnoses or simply advanced age.
Methods
An evidence-based literature review was performed assessing symptoms and clinical conditions associated with bone, neuropsychiatry, cognition, quality of life, and the neuromuscular system. The level of evidence and grade of recommendations were assigned to key studies to help determine recommendations regarding indications and potential benefits of parathyroidectomy (PTx).
Results
Symptoms ranging from decreased bone mineral density, increased fracture risk, neuropsychiatric symptoms and cognitive changes, lower quality of life, and neuromuscular symptoms were found to be associated with pHPT. The effects of PTx on these symptoms was addressed in a variety of studies that varied in quality.
Conclusion
Although there are few Level I randomized clinical trials addressing the benefit of PTx in patients with pHPT, there are supportive data to suggest that most patients with pHPT would benefit from operative cure.
Similar content being viewed by others
References
Eigelberger MS, Cheah WK, Ituarte PH et al.(2004) The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited? Ann Surg 239(4):528–535
Bilezikian JP, Potts JT Jr, Fuleihan Gel-H et al.(2002) Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Bone Miner Res 17(Suppl 2):N2–N11
Mack LA, Pasieka JL (2004) Asymptomatic primary hyperparathyroidism: a surgical perspective. Surg Clin North Am 84(3):803–816
Okamoto T, Kamo T, Obara T (2002) Outcome study of psychological distress and nonspecific symptoms in patients with mild primary hyperparathyroidism. Arch Surg 137(7):779–783; discussion 784
Pasieka JL, Parsons LL (1998) Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism. World J Surg 22(6):513–518; discussion 518–519
Sywak MS, Knowlton ST, Pasieka JL et al.(2002) Do the National Institutes of Health consensus guidelines for parathyroidectomy predict symptom severity and surgical outcome in patients with primary hyperparathyroidism? Surgery 132(6):1013–1019; discussion 1019–1020
NIH conference (1991) Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Ann Intern Med 114(7):593–597
Consensus conference (1991) Diagnosis and management of asymptomatic primary hyperparathyroidism. National Institutes of Health. Conn Med 55(6):349–354
Proceedings of the NIH Consensus Development Conference on diagnosis and management of asymptomatic primary hyperparathyroidism (1991) Bethesda, Maryland, October 29-31, 1990. J Bone Miner Res 6(Suppl 2):S1–S166
Consensus development conference statement (1991). J Bone Miner Res 6(Suppl 2):S9–S13
Mihai R, Wass JA, Sadler GP (2008) Asymptomatic hyperparathyroidism—need for multicentre studies. Clin Endocrinol (Oxf) 68(2):155–164
Uden P, Chan A, Duh QY et al.(1992) Primary hyperparathyroidism in younger and older patients: symptoms and outcome of surgery. World J Surg 16(4):791–797; discussion 798
Chan AK, Duh QY, Katz MH et al.(1995) Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. A case-control study. Ann Surg 222(3):402–412; discussion 412–414
Flint RS, Harman CR, Carter J et al.(2002) Primary hyperparathyroidism: referral patterns and outcomes of surgery. ANZ J Surg 72(3):200–203
Walgenbach S, Hommel G, Junginger T (2000) Outcome after surgery for primary hyperparathyroidism: ten-year prospective follow-up study. World J Surg 24(5):564–569; discussion 569–570
Hasse C, Sitter H, Bachmann S et al.(2000) How asymptomatic is asymptomatic primary hyperparathyroidism? Exp Clin Endocrinol Diabetes 108(4):265–274
Pasieka JL, Parsons LL, Demeure MJ et al.(2002) Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism. World J Surg 26(8):942–949
Kebebew E, Duh QY, Clark OH (2003) Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: a plea for early surgical referral. Arch Surg 138(8):867–871
Mihai R, Sadler GP (2008) Pasieka’s parathyroid symptoms scores correlate with SF-36 scores in patients undergoing surgery for primary hyperparathyroidism. World J Surg 32(5):807–814
Mittendorf EA, Wefel JS, Meyers CA et al.(2007) Improvement of sleep disturbance and neurocognitive function after parathyroidectomy in patients with primary hyperparathyroidism. Endocr Pract 13(4):338–344
Perrier ND, Coker LH, Rorie KD et al.(2006) Preliminary report: functional MRI of the brain may be the ideal tool for evaluating neuropsychologic and sleep complaints of patients with primary hyperparathyroidism. World J Surg 30(5):686–696
Prager G, Kalaschek A, Kaczirek K et al.(2002) Parathyroidectomy improves concentration and retentiveness in patients with primary hyperparathyroidism. Surgery 132(6):930–935; discussion 935–936
Burney RE, Jones KR, Christy B et al.(1999) Health status improvement after surgical correction of primary hyperparathyroidism in patients with high and low preoperative calcium levels. Surgery 125(6):608–614
Solomon BL, Schaaf M, Smallridge RC (1994) Psychologic symptoms before and after parathyroid surgery. Am J Med 96(2):101–106
Dralle H (2007) Evidence-based endocrine surgery: thyroid cancer. World J Surg 31(5):877–878
Sackett DL (1989) Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 95(2 Suppl):2S–4S
Heinrich S, Schäfer M, Rousson V et al.(2006) Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg 243(2):154–168
Minisola S, Rosso R, Romagnoli E (1998) Comment on marked improvement in bone mass after parathyroidectomy in osteitis fibrosa cystica. J Clin Endocrinol Metab 83(10):3760–3761
Chavda DV, Frock JT, Zielinski CM et al.(1998) Reversal of the histology of bone after parathyroidectomy in patients with hyperparathyroidism. J South Orthop Assoc 7(1):65–71
Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 4(6):368–381
Jorde R, Sundsfjord J (2000) Bone mineral density and blood pressure in patients with asymptomatic hyperparathyroidism. The Tromso Study. J Intern Med 247(3):325–330
Hagstrom E, Lundgren E, Mallmin H et al.(2006) Positive effect of parathyroidectomy on bone mineral density in mild asymptomatic primary hyperparathyroidism. J Intern Med 259(2):191–198
Abdelhadi M, Nordenstrom J (1998) Bone mineral recovery after parathyroidectomy in patients with primary and renal hyperparathyroidism. J Clin Endocrinol Metab 83(11):3845–3851
Sitges-Serra A, Girvent M, Pereira JA et al.(2004) Bone mineral density in menopausal women with primary hyperparathyroidism before and after parathyroidectomy. World J Surg 28(11):1148–1152
Christiansen P, Steiniche T, Brixen K et al.(1999) Primary hyperparathyroidism: short-term changes in bone remodeling and bone mineral density following parathyroidectomy. Bone 25(2):237–244
Lundgren E, Ljunghall S, Akerström G et al.(1998) Case-control study on symptoms and signs of “asymptomatic” primary hyperparathyroidism. Surgery 124(6):980–985; discussion 985–986
Bollerslev J, Jansson S, Mollerup CL et al.(2007) Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 92(5):1687–1692
Miller PD, Bilezikian JP (2002) Bone densitometry in asymptomatic primary hyperparathyroidism. J Bone Miner Res 17(Suppl 2):N98–N102
Silverberg SJ, Gartenberg F, Jacobs TP et al.(1995) Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. J Clin Endocrinol Metab 80(3):729–734
Lumachi F, Camozzi V, Ermani M et al.(2007) Bone mineral density improvement after successful parathyroidectomy in pre- and postmenopausal women with primary hyperparathyroidism: a prospective study. Ann N Y Acad Sci 1117:357–361
Ambrogini E, Cetani F, Cianferotti L et al.(2007) Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab 92(8):3114–3121
Rao DS, Phillips ER, Divine GW et al.(2004) Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89(11):5415–5422
Abe Y, Ejima E, Fujiyama K et al.(2000) Parathyroidectomy for primary hyperparathyroidism induces positive uncoupling and increases bone mineral density in cancellous bones. Clin Endocrinol (Oxf) 52(2):203–209
Christiansen P, Steiniche T, Brixen K et al.(1999) Primary hyperparathyroidism: effect of parathyroidectomy on regional bone mineral density in Danish patients: a three-year follow-up study. Bone 25(5):589–595
Nakaoka D, Sugimoto T, Kobayashi T et al.(2000) Prediction of bone mass change after parathyroidectomy in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 85(5):1901–1907
Nomura R, Sugimoto T, Tsukamoto T et al.(2004) Marked and sustained increase in bone mineral density after parathyroidectomy in patients with primary hyperparathyroidism: a six-year longitudinal study with or without parathyroidectomy in a Japanese population. Clin Endocrinol (Oxf) 60(3):335–342
Silverberg SJ, Shane E, Jacobs TP et al.(1999) A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 341(17):1249–1255
Lal G, Clark OH (2003) Primary hyperparathyroidism: controversies in surgical management. Trends Endocrinol Metab 14(9):417–422
Silverberg SJ, Shane E, de la Cruz L et al.(1989) Skeletal disease in primary hyperparathyroidism. J Bone Miner Res 4(3):283–291
Silverberg SJ, Bilezikian JP, Bone HG et al.(1999) Therapeutic controversies in primary hyperparathyroidism. J Clin Endocrinol Metab 84(7):2275–2285
Silverberg SJ, Gartenberg F, Jacobs TP et al.(1995) Longitudinal measurements of bone density and biochemical indices in untreated primary hyperparathyroidism. J Clin Endocrinol Metab 80(3):723–728
Marshall D, Johnell O, Wedel H (1996) Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 312(7041):1254–1259
Melton LJ 3rd, Atkinson EJ, O’Fallon WM et al.(1992) Risk of age-related fractures in patients with primary hyperparathyroidism. Arch Intern Med 152(11):2269–2273
Kochersberger G, Buckley NJ, Leight GS et al.(1987) What is the clinical significance of bone loss in primary hyperparathyroidism? Arch Intern Med 147(11):1951–1953
Larsson K, Ljunghall S, Krusemo UB et al.(1993) The risk of hip fractures in patients with primary hyperparathyroidism: a population-based cohort study with a follow-up of 19 years. J Intern Med 234(6):585–593
Khosla S, Melton J 3rd (2002) Fracture risk in primary hyperparathyroidism. J Bone Miner Res 17(Suppl 2):N103–N107
Vestergaard P, Mollerup CL, Frøkjaer VG et al.(2000) Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ 321(7261):598–602
Vestergaard P, Mosekilde L (2003) Fractures in patients with primary hyperparathyroidism: nationwide follow-up study of 1201 patients. World J Surg 27(3):343–349
Kenny AM, MacGillivray DC, Pilbeam CC et al.(1995) Fracture incidence in postmenopausal women with primary hyperparathyroidism. Surgery 118(1):109–114
Khosla S, Melton LJ 3rd, Wermers RA et al.(1999) Primary hyperparathyroidism and the risk of fracture: a population-based study. J Bone Miner Res 14(10):1700–1707
Vanderwalde LH, Liu IL, Haigh PI (2009) Effect of bone mineral density and parathyroidectomy on fracture risk in primary hyperparathyroidism. World J Surg 33(3):406–411
Vestergaard P, Mosekilde L (2003) Cohort study on effects of parathyroid surgery on multiple outcomes in primary hyperparathyroidism. BMJ 327(7414):530–534
Vanderwalde LH, Liu IL, O’Connell TX et al.(2006) The effect of parathyroidectomy on bone fracture risk in patients with primary hyperparathyroidism. Arch Surg 141(9):885–889; discussion 889–891
Okamoto T, Gerstein HC, Obara T (1997) Psychiatric symptoms, bone density and non-specific symptoms in patients with mild hypercalcemia due to primary hyperparathyroidism: a systematic overview of the literature. Endocr J 44(3):367–374
Coker LH, Rorie K, Cantley L et al.(2005) Primary hyperparathyroidism, cognition, and health-related quality of life. Ann Surg 242(5):642–650
Dotzenrath CM, Kaetsch AK, Pfingsten H et al.(2006) Neuropsychiatric and cognitive changes after surgery for primary hyperparathyroidism. World J Surg 30(5):680–685
Joborn C, Hetta J, Johansson H et al.(1988) Psychiatric morbidity in primary hyperparathyroidism. World J Surg 12(4):476–481
Talpos GB, Bone HG 3rd, Kleerekoper M et al.(2000) Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey. Surgery 128(6):1013–1020; discussion 1020–1021
Burney RE, Jones KR, Peterson M et al.(1998) Surgical correction of primary hyperparathyroidism improves quality of life. Surgery 124(6):987–991; discussion 991–992
Burney RE, Jones KR, Coon JW et al.(1996) Assessment of patient outcomes after operation for primary hyperparathyroidism. Surgery 120(6):1013–1018; discussion 1018–1019
Sheldon DG, Lee FT, Neil NJ et al.(2002) Surgical treatment of hyperparathyroidism improves health-related quality of life. Arch Surg 137(9):1022–1026; discussion 1026–1028
Quiros RM, Alef MJ, Wilhelm SM et al.(2003) Health-related quality of life in hyperparathyroidism measurably improves after parathyroidectomy. Surgery 134(4):675–681; discussion 681–683
Caillard C, Sebag F, Mathonnet M et al.(2007) Prospective evaluation of quality of life (SF-36v2) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up). Surgery 141(2):153–159; discussion 159–160
Pasieka JL, Parsons LL (2000) A prospective surgical outcome study assessing the impact of parathyroidectomy on symptoms in patients with secondary and tertiary hyperparathyroidism. Surgery 128(4):531–539
Greutelaers B, Kullen K, Kollias J et al.(2004) Pasieka Illness Questionnaire: its value in primary hyperparathyroidism. ANZ J Surg 74(3):112–115
Chou FF, Sheen-Chen SM, Leong CP (1995) Neuromuscular recovery after parathyroidectomy in primary hyperparathyroidism. Surgery 117(1):18–25
Turken SA, Cafferty M, Silverberg SJ et al.(1989) Neuromuscular involvement in mild, asymptomatic primary hyperparathyroidism. Am J Med 87(5):553–557
Deutch SR, Jensen MB, Christiansen PM et al.(2000) Muscular performance and fatigue in primary hyperparathyroidism. World J Surg 24(1):102–107
Edwards ME, Rotramel A, Beyer T et al.(2006) Improvement in the health-related quality-of-life symptoms of hyperparathyroidism is durable on long-term follow-up. Surgery 140(4):655–663; discussion 653–654
Kristoffersson A, Bostrom A, Soderberg T (1992) Muscle strength is improved after parathyroidectomy in patients with primary hyperparathyroidism. Br J Surg 79(2):165–168
Joborn C, Joborn H, Rastad J et al.(1988) Maximal isokinetic muscle strength in patients with primary hyperparathyroidism before and after parathyroid surgery. Br J Surg 75(1):77–80
Jansson S, Grimby G, Hagne I et al.(1991) Muscle structure and function before and after surgery for primary hyperparathyroidism. Eur J Surg 157(1):13–16
Colliander EB, Strigård K, Westblad P et al.(1998) Muscle strength and endurance after surgery for primary hyperparathyroidism. Eur J Surg 164(7):489–494
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Caron, N.R., Pasieka, J.L. What Symptom Improvement Can Be Expected After Operation for Primary Hyperparathyroidism?. World J Surg 33, 2244–2255 (2009). https://doi.org/10.1007/s00268-009-9987-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-009-9987-4